<DOC>
	<DOCNO>NCT01057511</DOCNO>
	<brief_summary>Crinone micronized progesterone gel administrate via vaginal route target drug delivery uterine ( first uterine pas effect ) low serum concentration . This study investigate difference progesterone concentration serum endometrium administration crinone intramuscular progesterone . The study conduct single centre , randomize , active control study . Recruitment duration 6-8 month long . Day 1 Crinone administration baseline . On Day 7 Crinone administration endometrial tissue take P4 test . Last visit 3-5 day withdraw bleeding .</brief_summary>
	<brief_title>Compare Difference P4 Concentration Serum Endometrium After Vaginal IM P Administration</brief_title>
	<detailed_description />
	<mesh_term>Progesterone</mesh_term>
	<criteria>Perimenopausal woman age &lt; 55 year old amenorrhea &gt; =2 month reproductive age woman amenorrhea &gt; = 6months due premature ovarian failure reason . ; Serum progesterone level &lt; 1ng/mL Endometrial thickness â‰¥5mm No contraindication progesterone administration ; Informed consent sign . The kind progestin apply 1 month recruitment ; Any serious disease allow receive progestin treatment ; Under vaginal treatment ; Any vaginal infectious disease ; Any hormone treatment contraindication ; drug abuse untreated STD ; Prior hypersensitivity Crinone one excipients . Pregnant woman indicate hCG positive .</criteria>
	<gender>Female</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>April 2012</verification_date>
	<keyword>Crinone</keyword>
	<keyword>progesterone</keyword>
	<keyword>endometrial progesterone concentration</keyword>
</DOC>